# Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With Sorafenib

> **NCT02786342** · — · UNKNOWN · sponsor: **Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS** · enrollment: 160 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** blood sample collection

## Key facts

- **NCT ID:** NCT02786342
- **Lead sponsor:** Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02-15
- **Primary completion:** 2021-06
- **Final completion:** 2021-06
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2021-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02786342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02786342, "Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With Sorafenib". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02786342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*